Does new permanent pacemaker implantation after transcatheter aortic valve replacement affect morbidity, mortality, and health care costs?
New permanent pacemaker implantation after TAVR is associated with increased long-term morbidity and mortality, though without a significant difference in post-discharge cumulative healthcare costs.
New permanent pacemaker implantation after transcatheter aortic valve replacement was associated with significantly greater morbidity and mortality at long-term follow-up. However, this did not translate to a difference in cumulative health care costs after hospital discharge.
Aljabbary et al. (Fri,) studied this question.